Royal Bank of Canada’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.67M Buy
128,199
+123,502
+2,629% +$1.61M ﹤0.01% 3164
2025
Q1
$49K Buy
4,697
+3,262
+227% +$34K ﹤0.01% 5204
2024
Q4
$24K Sell
1,435
-1,928
-57% -$32.2K ﹤0.01% 5540
2024
Q3
$79K Sell
3,363
-288
-8% -$6.77K ﹤0.01% 5026
2024
Q2
$88K Sell
3,651
-4,334
-54% -$104K ﹤0.01% 4954
2024
Q1
$270K Sell
7,985
-3,658
-31% -$124K ﹤0.01% 4023
2023
Q4
$366K Buy
11,643
+4,012
+53% +$126K ﹤0.01% 4038
2023
Q3
$195K Buy
7,631
+2,558
+50% +$65.4K ﹤0.01% 4353
2023
Q2
$145K Sell
5,073
-1,813
-26% -$51.8K ﹤0.01% 4590
2023
Q1
$165K Buy
6,886
+905
+15% +$21.7K ﹤0.01% 4414
2022
Q4
$101K Buy
5,981
+1,934
+48% +$32.7K ﹤0.01% 4972
2022
Q3
$60K Sell
4,047
-173
-4% -$2.57K ﹤0.01% 5153
2022
Q2
$67K Sell
4,220
-1,816
-30% -$28.8K ﹤0.01% 5116
2022
Q1
$163K Sell
6,036
-3,953
-40% -$107K ﹤0.01% 4792
2021
Q4
$370K Buy
9,989
+2,547
+34% +$94.3K ﹤0.01% 4237
2021
Q3
$356K Buy
7,442
+5,447
+273% +$261K ﹤0.01% 4148
2021
Q2
$68K Buy
1,995
+34
+2% +$1.16K ﹤0.01% 5340
2021
Q1
$81K Sell
1,961
-1,115
-36% -$46.1K ﹤0.01% 5106
2020
Q4
$133K Sell
3,076
-9,755
-76% -$422K ﹤0.01% 4617
2020
Q3
$550K Buy
12,831
+5,701
+80% +$244K ﹤0.01% 3333
2020
Q2
$334K Buy
7,130
+6,130
+613% +$287K ﹤0.01% 3652
2020
Q1
$14K Buy
+1,000
New +$14K ﹤0.01% 5190
2019
Q4
Sell
-122
Closed -$1K 6174
2019
Q3
$1K Buy
+122
New +$1K ﹤0.01% 5721
2018
Q4
Sell
-17
Closed 5783
2018
Q3
$0 Buy
+17
New ﹤0.01% 6078
2017
Q1
Hold
0
5881
2016
Q4
Hold
0
5838